This website will be unavailable from Thursday, May 30, 2024 at 6:00 p.m. through Monday, June 3, 2024 at 7:00 a.m. due to data center maintenance.

LEGISLATIVE BUDGET BOARD
Austin, Texas
 
FISCAL NOTE, 87TH LEGISLATIVE REGULAR SESSION
 
April 28, 2021

TO:
Honorable Tom Oliverson, Chair, House Committee on Insurance
 
FROM:
Jerry McGinty, Director, Legislative Budget Board
 
IN RE:
HB3922 by Oliverson (relating to information provided by health care providers and hospitals to certain patients regarding pharmaceutical manufacturer patient assistance programs for insulin.), Committee Report 1st House, Substituted

No significant fiscal implication to the State is anticipated.

The bill would require health care providers and hospitals that receive uncompensated care pool payments to provide a patient diagnosed with diabetes who requires insulin information regarding the availability of pharmaceutical manufacturer patient assistance programs that may reduce the cost of insulin to the patient. The Health and Human Services Commission indicates it could absorb the costs associated with the bill within current resources.

Local Government Impact

No significant fiscal implication to units of local government is anticipated.


Source Agencies:
304 Comptroller of Public Accounts, 529 Hlth & Human Svcs Comm
LBB Staff:
JMc, AAL, RD, JLI